Retrosynthesis explained: An interview with Tim Cernak
This podcast is brought to you by the Science/AAAS Custom Publishing Office
>> Download Podcast
Chemical synthesis is the foundation of small molecule drug development. Technological and computational breakthroughs have brought about a renaissance in this field, particularly for retrosynthesis, which describes the process of working backwards from a target product to determine the quickest and most cost effective pathways to generate that target. This promises to have a significant impact on the generation of new, more potent, and more personalized medications.
In this conversation, I interview Dr. Tim Cernak from University of Michigan about recent advances in retrosynthesis and some of the ongoing challenges.
For more information about Synthia™ retrosynthesis software, please go to:
[Music: Ice Climb/Podington Bear; Podcast editing: Castos; Podcast production: Sean Sanders]